We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-3.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$58.4M
AUM Growth
-$35.8M
Cap. Flow
-$33.5M
Cap. Flow %
-57.3%
Top 10 Hldgs %
41.11%
Holding
109
New
27
Increased
13
Reduced
25
Closed
40

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$2.5M
2
NXPI icon
NXP Semiconductors
NXPI
+$2.09M
3
WDC icon
Western Digital
WDC
+$1.49M
4
CI icon
Cigna
CI
+$1.16M
5
NVS icon
Novartis
NVS
+$962K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
HUM icon
Humana
HUM
+$2.73M
3
BABA icon
Alibaba
BABA
+$2.34M
4
DIS icon
Walt Disney
DIS
+$1.74M
5
PYPL icon
PayPal
PYPL
+$1.72M

Sector Composition

Rank Sector Weight
1 Healthcare 49.52%
2 Technology 26.41%
3 Financials 2.04%
4 Communication Services 1.9%
5 Consumer Discretionary 1.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MKSI icon
26
MKS Inc
MKSI
$20.6B
$803K 1.37%
+8,701
New +$719K
DXCM icon
27
DexCom
DXCM
$32B
$794K 1.36%
21,292
-1,980
-9% -$76.9K
MOH icon
28
Molina Healthcare
MOH
$10.3B
$788K 1.35%
7,183
-434
-6% -$56.2K
MYOK
29
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$768K 1.32%
14,720
-2,552
-15% -$136K
V icon
30
Visa
V
$677B
$761K 1.3%
+4,427
New +$789K
AMD icon
31
Advanced Micro Devices
AMD
$789B
$750K 1.28%
+25,859
New +$811K
BOLD
32
DELISTED
Audentes Therapeutics, Inc
BOLD
$713K 1.22%
25,370
-693
-3% -$23.7K
PTCT icon
33
PTC Therapeutics
PTCT
$6.12B
$677K 1.16%
+20,028
New +$872K
TWTR
34
DELISTED
Twitter, Inc.
TWTR
$651K 1.11%
15,797
-21,277
-57% -$869K
CTLT
35
DELISTED
CATALENT, INC.
CTLT
$646K 1.11%
13,562
+5,610
+71% +$301K
COUP
36
DELISTED
Coupa Software Incorporated
COUP
$618K 1.06%
4,773
-444
-9% -$61.5K
SAGE
37
DELISTED
Sage Therapeutics
SAGE
$599K 1.03%
+4,267
New +$714K
QURE icon
38
uniQure
QURE
$3.22B
$579K 0.99%
14,711
+12,750
+650% +$736K
NVRO
39
DELISTED
NEVRO CORP.
NVRO
$496K 0.85%
5,767
-5,722
-50% -$433K
ICLR icon
40
Icon
ICLR
$12.7B
$473K 0.81%
3,212
+1,533
+91% +$235K
LYV icon
41
Live Nation Entertainment
LYV
$42.1B
$433K 0.74%
+6,525
New +$456K
BABA icon
42
Alibaba
BABA
$308B
$423K 0.72%
2,532
-13,639
-84% -$2.34M
MRTX
43
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$418K 0.72%
+5,370
New +$504K
VC icon
44
Visteon
VC
$2.78B
$408K 0.7%
+4,944
New +$330K
MCK icon
45
CALL
McKesson
MCK
$101B
$396K 0.68%
+2,900
New +$411K
PBYI icon
46
Puma Biotechnology
PBYI
$454M
$365K 0.63%
33,866
+6,299
+23% +$68K
GS icon
47
Goldman Sachs
GS
$303B
$324K 0.55%
+1,562
New +$327K
AERI
48
DELISTED
Aerie Pharmaceuticals
AERI
$322K 0.55%
+16,731
New +$383K
CSII
49
DELISTED
Cardiovascular Systems, Inc.
CSII
$281K 0.48%
5,915
+843
+17% +$39.6K
INSP icon
50
Inspire Medical Systems
INSP
$1.74B
$217K 0.37%
+3,549
New +$234K
1
2
3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Partner Investment Management held 109 positions worth $58.4M, down 38% from $94.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Partner Investment Management withdrew a net $33.5M in Q3 2019, closing 40 positions and reducing 25 holdings. Its most notable exit was Humana, an estimated $2.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 44% a quarter earlier, followed by Technology and Financials.

Against the trend, Partner Investment Management opened a new position in Alexion Pharmaceuticals worth $2.17M.

  • Partner Investment Management's largest Q3 2019 buy was Alexion Pharmaceuticals: 22,136 shares worth $2.17M.
  • Partner Investment Management added most to Twilio in Q3 2019, an estimated $926K increase.
  • Partner Investment Management's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $3.44M.
  • Partner Investment Management fully exited Humana in Q3 2019, selling an estimated $2.73M.
  • Partner Investment Management's ten largest holdings make up 41% of its $58.4M portfolio in Q3 2019.
  • Partner Investment Management opened 27 new positions and closed 40 in Q3 2019.
  • Partner Investment Management's portfolio value fell 38% quarter-over-quarter to $58.4M.

Based on Partner Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.